A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Oral LB20304 (Gemifloxacin) at Doses of 160mg or 320mg (Equivalent to 200mg or 400mg of the Mesylate Salt) Once Daily for 7 Days for the Treatment of Acute Exacerbations of Chronic Bronchitis (AECB) in Korean Adult Population

Autor:	In Gyou Hyeon, Tae Sun Shim, Won Dong Kim, Young Soo Shim, Byoung Whui Choi, Jae Yeol Kim, Kye Young Lee, Young Whan Kim, Gui Hyun Nam, Eun Kyung Mo, Jae Seuk Park, Seung Joon Lee, Hojoong Kim, Ju Ock Kim, Ki Suck Jung, Hong Mo Kang, O Jung Kwon
Rok vydání:	2003
Předmět:	Pulmonary and Respiratory Medicine Chronic bronchitis medicine.medical_specialty Mesylate business.industry Gemifloxacin Adult population Double blind study chemistry.chemical_compound Infectious Diseases chemistry Internal medicine medicine Once daily Intensive care medicine business medicine.drug
Zdroj:	Tuberculosis and Respiratory Diseases. 55:69
ISSN:	0378-0066
DOI:	10.4046/trd.2003.55.1.69
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::86912b15ade467a541016104889d1714 https://doi.org/10.4046/trd.2003.55.1.69